NCT05765851

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2023-05-30Est. Completion: 2029-05-31

Enrollment target: 128 participants

Locations

Florida Cancer Specialists, Sarasota, Florida, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Lifespan Cancer Institute, Providence, Rhode Island, United States
University of Utah, Salt Lake City, Utah, United States
NEXT Oncology, Fairfax, Virginia, United States
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Centre Léon Bérard, Lyon, France
Oncopole - Institut Claudius Regaud, Toulouse, France
Gifu University Hospital, Gifu, Japan
Shizuoka Cancer Center, Nakatogari, Japan
The University of Osaka Hospital, Osaka, Japan
The Cancer Institute Hospital Of JFCR, Tokyo, Japan
Hospital Universitari Vall d'Hebron, Barcelona, Spain
National Cheng Kung University Hospital, Tainan, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan

Other microbiome trials you might be interested in

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerPhase 2Recruiting

Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7

This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…

Mobile, United StatesEst. completion Nov 6, 2020

View Trial →

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Phase 3Recruiting

Non-small Cell Lung Cancer

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.